BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8232234)

  • 21. Endogenous adenosine reduces glutamatergic output from rods through activation of A2-like adenosine receptors.
    Stella SL; Bryson EJ; Cadetti L; Thoreson WB
    J Neurophysiol; 2003 Jul; 90(1):165-74. PubMed ID: 12843308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine A3 agonist cardioprotection in isolated rat and rabbit hearts is blocked by the A1 antagonist DPCPX.
    Kilpatrick EL; Narayan P; Mentzer RM; Lasley RD
    Am J Physiol Heart Circ Physiol; 2001 Aug; 281(2):H847-53. PubMed ID: 11454590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulatory role of adenosine receptors in insect motor nerve terminals.
    Magazanik LG; Fedorova IM
    Neurochem Res; 2003 Apr; 28(3-4):617-24. PubMed ID: 12675152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation by presynaptic adenosine A1 receptors of nicotinic receptor antagonist-induced neuromuscular block in the mouse.
    Prior C; Breadon EL; Lindsay KE
    Eur J Pharmacol; 1997 May; 327(2-3):103-8. PubMed ID: 9200547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual activation of adenosine A1 and A3 receptors mediates preconditioning of isolated cardiac myocytes.
    Wang J; Drake L; Sajjadi F; Firestein GS; Mullane KM; Bullough DA
    Eur J Pharmacol; 1997 Feb; 320(2-3):241-8. PubMed ID: 9059860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine antagonists prevent hypoxia-induced depression of excitatory but not inhibitory synaptic currents.
    Katchman AN; Hershkowitz N
    Neurosci Lett; 1993 Sep; 159(1-2):123-6. PubMed ID: 8264952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for constitutively-active adenosine receptors at mammalian motor nerve endings.
    Searl TJ; Silinsky EM
    Eur J Pharmacol; 2012 Jun; 685(1-3):38-41. PubMed ID: 22542659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of purines on calcium-independent acetylcholine release at the mouse neuromuscular junction.
    Veggetti M; Muchnik S; Losavio A
    Neuroscience; 2008 Jul; 154(4):1324-36. PubMed ID: 18534762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A2A and A3 receptors mediate the adenosine-induced relaxation in spontaneously active possum duodenum in vitro.
    Woods CM; Toouli J; Saccone GT
    Br J Pharmacol; 2003 Apr; 138(7):1333-9. PubMed ID: 12711634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines.
    Sebastião AM; Stone TW; Ribeiro JA
    Br J Pharmacol; 1990 Oct; 101(2):453-9. PubMed ID: 2257444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine depresses transmitter release but is not the basis for 'tetanic fade' at the neuromuscular junction of the rat.
    Malinowski MN; Cannady SB; Schmit KV; Barr PM; Schrock JW; Wilson DF
    Neurosci Lett; 1997 Jul; 230(2):81-4. PubMed ID: 9259469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative cross-talk between presynaptic adenosine and acetylcholine receptors.
    Shakirzyanova AV; Bukharaeva EA; Nikolsky EE; Giniatullin RA
    Eur J Neurosci; 2006 Jul; 24(1):105-15. PubMed ID: 16800865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the adenosine-mediated synaptic inhibition in the CA3 area of immature and adult rat hippocampus.
    Descombes S; Avoli M; Psarropoulou C
    Brain Res Dev Brain Res; 1998 Sep; 110(1):51-9. PubMed ID: 9733916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine inhibits N-type calcium channels at the rat neuromuscular junction.
    Schwartz AD; Whitacre CL; Lin Y; Wilson DF
    Clin Exp Pharmacol Physiol; 2003 Mar; 30(3):174-7. PubMed ID: 12603347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones.
    Nörenberg W; Wirkner K; Illes P
    Br J Pharmacol; 1997 Sep; 122(1):71-80. PubMed ID: 9298530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosinergic modulation of respiratory neurones in the neonatal rat brainstem in vitro.
    Herlenius E; Lagercrantz H
    J Physiol; 1999 Jul; 518(Pt 1):159-72. PubMed ID: 10373698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Ado A1- and A2-receptor activation on ventricular fibrillation during hypoxia-reoxygenation.
    Chi L; Friedrichs GS; Oh JY; Green AL; Lucchesi BR
    Am J Physiol; 1994 Oct; 267(4 Pt 2):H1447-54. PubMed ID: 7943390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel irreversible antagonist of the A1-adenosine receptor.
    Srinivas M; Shryock JC; Scammells PJ; Ruble J; Baker SP; Belardinelli L
    Mol Pharmacol; 1996 Jul; 50(1):196-205. PubMed ID: 8700113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A1 adenosine receptor modulation of electrically-evoked contractions in the bisected vas deferens and cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Jul; 124(5):964-70. PubMed ID: 9692782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of [3H]acetylcholine release from cultured amacrine-like neurons by adenosine A1 receptors.
    Santos PF; Santos MS; Carvalho AP; Duarte CB
    J Neurochem; 1998 Sep; 71(3):1086-94. PubMed ID: 9721733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.